<i>In vivo</i> metabolomics identifies CD38 as an emergent vulnerability in <i>LKB1</i> -mutant lung cancer
Jiehui Deng(NYU Langone Health), Kwok‐Kin Wong(NYU Langone Health)
Cited by 1
Related Papers
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
|Nature Medicine|2008|1.3k
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
|Cell|2009|1k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701